Simplex Trading
VOR icon

Simplex Trading’s Vor Biopharma VOR Stock Holding History

Simplex Trading’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-348
Closed -$3.08K – 9832
2025
Q1 		$4K Buy
348
+120
+53% +$2.88K ﹤0.01% 7740
2024
Q4 		$5K Sell
228
-25
-10% -$414 ﹤0.01% 7673
2024
Q3 		$3K Buy
+253
New +$4.61K ﹤0.01% 7904
2024
Q1 		– Sell
-40
Closed -$1.76K – 10004
2023
Q4 		$1K Buy
+40
New +$1.65K ﹤0.01% 8608
2023
Q3 		– Sell
-15
Closed – – 9944
2023
Q2 		$0 Buy
+15
New +$1.37K ﹤0.01% 10046
2023
Q1 		– Sell
-352
Closed -$46K – 10228
2022
Q4 		$46K Buy
352
+180
+105% +$17.8K ﹤0.01% 5997
2022
Q3 		$13K Buy
+172
New +$16.9K ﹤0.01% 8018

Other funds holding VOR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACM
Ariose Capital Management Central, Hong Kong, Hong Kong $149M AUM 287.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Simplex Trading's VOR Position: Q2 2025 in Review

Simplex Trading sold out of Vor Biopharma (VOR) in Q2 2025, closing a stake of 348 shares — an estimated $3.08K sold.

Simplex Trading first reported a position in VOR in Q3 2022 and held it in 7 quarters. The position peaked at $46K in Q4 2022. 35 funds tracked by Wall St. Rank hold VOR as of Q2 2025.

  • Simplex Trading reported no remaining Vor Biopharma position as of Q2 2025 after selling out during the quarter.
  • Simplex Trading sold 348 Vor Biopharma shares in Q2 2025, an estimated $3.08K.
  • Simplex Trading first reported a position in Vor Biopharma in Q3 2022 and held it in 7 quarters.
  • Simplex Trading's Vor Biopharma position peaked at $46K in Q4 2022.
  • 35 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2025.

Based on Simplex Trading's 13F filing for Q2 2025, filed 5 Aug 2025.